ROYAL BANK OF CANADA - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$12,845,000
-52.1%
317,786
-31.7%
0.01%
-52.6%
Q2 2015$26,794,000
-7.3%
465,561
+2.6%
0.02%
-5.0%
Q1 2015$28,903,000
-11.3%
453,941
-14.0%
0.02%
-4.8%
Q4 2014$32,601,000
+42.4%
528,032
-10.4%
0.02%
+31.2%
Q3 2014$22,894,000
+313.5%
589,590
+266.8%
0.02%
+300.0%
Q2 2014$5,537,000
-36.2%
160,735
-20.0%
0.00%
-33.3%
Q1 2014$8,685,000
+257.7%
200,986
+229.7%
0.01%
+200.0%
Q4 2013$2,428,000
+116.8%
60,966
+104.4%
0.00%
+100.0%
Q3 2013$1,120,000
+78.1%
29,823
+27.4%
0.00%0.0%
Q2 2013$629,00023,4050.00%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders